About US
Contact us
-
Mylan launches authorised generic version of EpiPenUS-based Mylan has launched the authorised generic version of EpiPen (epinephrine injection, USP) auto-injector, after the recent price hike criticism. The self-injectable device (auto-injector) cont2016/12/29
-
CMA accuses Actavis UK of overcharging NHS for hydrocortisone tabletsThe UK’s primary competition and consumer authority CMA has accused Actavis of overcharging the NHS for hydrocortisone tablets. These tablets are used as the primary replacement therapy for people wh2016/12/28
-
UK researchers say saliva testing could form new tool to assess immunityResearchers from the University of Birmingham, UK, have revealed that testing antibody levels in saliva may offer a new way to check immunity to protect against bacterial infections. The researchers2016/12/28
-
GSK opens new global vaccines R&D centre in USGlaxoSmithKline (GSK) has opened its new global vaccines research and development (R&D) centre in Rockville, Maryland, as part of plans to expand its vaccines presence in the US. The company will2016/12/27
-
BTG launches DC Bead LUMI for liver cancer patients in CanadaBTG International has launched a next-generation treatment option, DC Bead LUMI, for cancer patients in Canada, marking its first worldwide market commercialisation. Based on the technology platfor2016/12/27
-
Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma CorporationUS-based biopharmaceutical companyIncyte Corporationhas entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS Pharma. The agreement w2016/12/26
-
M&As this week: CiToxLAB, Sichuan Kelun PharmaFrench-based pre-clinical services providerCiToxLAB Grouphas announced that it has acquired a pre-clinical contract research company known as AccelLAB. "The acquisition is expected to foster the acqu2016/12/26
-
European research groups partner to develop new vaccine against Zika virusResearch groups in Europe have joined forces to develop a new vaccine against the Zika virus. The ZIKAVAX consortium is supported by €5m funding from the EU's Horizon 2020 programme and comprises The2016/12/23
-
Sanofi’s Jevtana drug receives SMC approval to treat prostate cancerThe Scottish Medicines Consortium (SMC) has accepted Sanofi Genzyme’s Jevtana (cabazitaxel) for routine use in NHS Scotland to treat metastatic hormone-refractory prostate cancer (mHRPC). Jevtana (ca2016/12/23
-
Herantis Pharma secures EU Horizon 2020 programme grant for Parkinson studyFinnish company Herantis Pharma has secured a grant from the European Union (EU) for the Phase I-II clinical study with its drug candidate cerebral dopamine neurotrophic factor (CDNF) to treat Parkins2016/12/22